Alternative low-populated conformations prompt phase transitions in polyalanine repeat expansions

Abnormal trinucleotide repeat expansions alter protein conformation causing malfunction and contribute to a significant number of incurable human diseases. Scarce structural insights available on disease-related homorepeat expansions hinder the design of effective therapeutics. Here, we present the dynamic structure of human PHOX2B C-terminal fragment, which contains the longest polyalanine segment known in mammals. The major α-helical conformation of the polyalanine tract is solely extended by polyalanine expansions in PHOX2B, which are responsible for most congenital central hypoventilation syndrome cases. However, polyalanine expansions in PHOX2B additionally promote nascent homorepeat conformations that trigger length-dependent phase transitions into solid condensates that capture wild-type PHOX2B. Remarkably, HSP70 and HSP90 chaperones specifically seize PHOX2B alternative conformations preventing phase transitions. The precise observation of emerging polymorphs in expanded PHOX2B postulates unbalanced phase transitions as distinct pathophysiological mechanisms in homorepeat expansion diseases, paving the way towards the search of therapeutics modulating biomolecular condensates in central hypoventilation syndrome.

A close-up view of the phase separation of PHOX2B.

When Proteins Misbehave: How Polyalanine Expansions Trigger Disease Through Phase Transitions

Introduction

Imagine a genetic typo that causes a protein to repeat the same amino acid over and over, like a broken record. In human genetics, these "trinucleotide repeat expansions" are responsible for numerous incurable diseases, yet we've struggled to understand exactly how they cause harm at the molecular level. A groundbreaking study published in *Nature Communications* by Antón and colleagues sheds new light on this puzzle by examining PHOX2B, a protein containing the longest polyalanine stretch known in mammals. When this stretch expands beyond its normal length, it causes congenital central hypoventilation syndrome (CCHS) a life-threatening condition where patients lose the automatic ability to breathe.

What makes this research particularly exciting is its revelation of an unexpected culprit: phase transitions. The expanded protein doesn't simply misfold it undergoes dramatic physical transformations that trap normal proteins in solid condensates, disrupting cellular function. Even more remarkably, the study identifies molecular chaperones as guardians that can prevent these catastrophic transitions, opening new therapeutic avenues for this devastating disease.

Key Findings

The Dual Nature of Expanded PHOX2B

The research team discovered that PHOX2B's polyalanine tract normally adopts a stable, extended alpha-helical structure the longest such helix characterized in mammals. In healthy individuals, this structure functions properly. However, when genetic mutations cause the polyalanine segment to expand (as occurs in most CCHS cases), something unexpected happens: the protein develops a split personality.

While the expanded polyalanine tract maintains its predominant alpha-helical conformation, it simultaneously begins to populate alternative, "nascent" conformations.

Phase Transitions: From Liquid to Solid

The most striking discovery is that these alternative conformations trigger length-dependent phase transitions. As the polyalanine expansion grows longer, the protein increasingly undergoes rapid transitions from a soluble state into solid condensates. This isn't gradual aggregation it's a dramatic phase separation, similar to how water suddenly freezes into ice.

These solid condensates pose a double threat. First, they sequester the mutant PHOX2B protein, preventing it from performing its normal function as a transcription factor essential for autonomic nervous system development. Second, and perhaps more insidiously, these condensates capture wild-type PHOX2B proteins, creating a dominant-negative effect that amplifies the disease phenotype. This explains why even individuals with one normal copy of the gene develop severe symptoms.

Chaperones as Molecular Guardians

In a remarkable twist, the researchers found that HSP70 and HSP90—two well-known molecular chaperones act as specific sentinels against these phase transitions. These chaperones don't simply bind to misfolded proteins indiscriminately. Instead, they specifically recognize and capture the alternative, low-populated conformations of PHOX2B before they can trigger phase separation.

This selectivity is crucial: the chaperones essentially "see" the dangerous conformations emerging and neutralize them, preventing the cascade that leads to solid condensate formation. By maintaining PHOX2B in its functional alpha-helical state, these chaperones preserve both the mutant and wild-type proteins in their active forms.

Mechanisms

Structural Polymorphism and Conformational Dynamics

Using sophisticated nuclear magnetic resonance (NMR) spectroscopy—the gold standard for observing protein dynamics in solution the team mapped out the conformational landscape of PHOX2B with unprecedented detail. The polyalanine tract exists in a dynamic equilibrium between multiple states:

1. Major conformation: An extended, rigid alpha-helix that represents the functional state

2. Nascent disordered conformations: Flexible, unstructured regions that appear transiently

3. Beta-strand conformations: Rare but critical structures that promote intermolecular associations

The expansion of the polyalanine tract shifts this equilibrium, increasing the population of the alternative conformations. While these remain minority species, their presence creates nucleation sites for phase separation. The researchers demonstrated that this is a length-dependent phenomenon—longer expansions produce more frequent transitions and more stable condensates.

The Phase Separation Cascade

The mechanism unfolds in several steps:

1. Nucleation: Alternative conformations expose surfaces that promote protein-protein interactions

2. Oligomerization: Multiple PHOX2B molecules begin to associate through their polyalanine regions

3. Phase separation: Rapid de-mixing occurs, with PHOX2B concentrating into distinct condensates

4. Solidification: Unlike typical liquid-liquid phase separation seen in many cellular condensates, these structures rapidly mature into solid, irreversible aggregates

5. Sequestration: Both mutant and wild-type PHOX2B become trapped, depleting functional protein from the nucleus

Chaperone Intervention Mechanism

HSP70 and HSP90 interrupt this cascade at the earliest stage. Through NMR titration experiments, the researchers showed that these chaperones bind preferentially to the nascent conformations—the very structures that initiate phase separation. By stabilizing PHOX2B in its alpha-helical state and preventing the conformational excursions that lead to oligomerization, the chaperones effectively block the entire pathological cascade.

This represents a form of "conformational triage," where chaperones continuously survey the protein population and rescue molecules that begin to deviate from their functional structure. The specificity of this interaction suggests that cells have evolved sophisticated quality control mechanisms to manage the inherent instability of polyalanine repeats.

Implications

Redefining Disease Mechanisms in Repeat Expansion Disorders

This study fundamentally changes how we think about trinucleotide repeat expansion diseases. The traditional model focused on toxic protein aggregation—clumps of misfolded protein that physically damage cells. The PHOX2B findings reveal a more nuanced mechanism: unbalanced phase transitions that disrupt the normal organization of cellular components.

This distinction matters because phase transitions are, in principle, reversible. Unlike irreversible protein aggregates that must be degraded, phase-separated condensates can potentially be dissolved by shifting the thermodynamic equilibrium. This opens conceptually new therapeutic strategies focused on modulating condensate formation rather than simply clearing aggregates.

Therapeutic Opportunities

The identification of HSP70 and HSP90 as natural suppressors of PHOX2B phase transitions immediately suggests therapeutic approaches:

1. Chaperone enhancement: Small molecules that boost HSP70/HSP90 activity or expression could help prevent condensate formation in CCHS patients

2. Conformational stabilizers: Compounds that specifically stabilize the alpha-helical conformation of the polyalanine tract could reduce the population of dangerous alternative conformations

3. Phase transition modulators: Drugs that alter the thermodynamic properties of PHOX2B condensates could prevent their solidification or promote their dissolution

Beyond CCHS, these insights may apply to other polyalanine expansion diseases, including several forms of syndactyly, holoprosencephaly, and cleidocranial dysplasia. The study establishes a framework for investigating whether phase transitions contribute to pathology in these related conditions.

Broader Impact on Protein Science

The research also advances our fundamental understanding of how cells manage repetitive protein sequences. Homorepeats are surprisingly common in eukaryotic proteomes, yet their structural biology has remained largely mysterious due to technical challenges. By successfully characterizing the longest mammalian polyalanine tract using advanced NMR techniques, this study provides a methodological roadmap for investigating other difficult-to-study repetitive proteins.

The finding that low-populated conformations can drive major biological consequences challenges the traditional structure-function paradigm, which typically focuses on the most abundant protein state. It suggests that rare conformational excursions—"dark states" that exist only transiently—may play critical roles in both normal protein function and disease pathogenesis.

Clinical Significance for CCHS

For the CCHS community, this research offers hope. Congenital central hypoventilation syndrome is a devastating disorder where affected individuals lack the automatic drive to breathe, requiring lifelong ventilatory support. Most cases arise from polyalanine expansions in PHOX2B, yet treatment options remain limited to managing symptoms rather than addressing the underlying molecular defect.

The demonstration that chaperones can prevent the pathological phase transitions suggests that pharmacological chaperone therapy—already being explored for other protein misfolding diseases—could be adapted for CCHS. While translating these findings to the clinic will require extensive additional research, the study provides the first clear molecular target for disease-modifying therapy.

Conclusion

The work by Antón and colleagues represents a landmark achievement in understanding how polyalanine repeat expansions cause disease. By revealing that PHOX2B undergoes length-dependent phase transitions driven by alternative protein conformations, and that molecular chaperones can prevent these transitions, the study illuminates both the pathological mechanism of CCHS and potential therapeutic strategies.

Perhaps most importantly, this research exemplifies how detailed structural and biophysical studies can transform our understanding of genetic diseases. The precise observation of emerging polymorphs and phase transitions in expanded PHOX2B provides a conceptual framework that may extend to numerous other repeat expansion disorders, potentially benefiting patients with a wide range of currently incurable conditions.

As we continue to unravel the complex relationship between protein structure, dynamics, and disease, studies like this remind us that nature's solutions in this case, the chaperone system—often point the way toward therapeutic interventions. The challenge now is to harness these insights, developing drugs that can mimic or enhance the protective effects of HSP70 and HSP90, offering hope to individuals living with congenital central hypoventilation syndrome and related disorders.

---

Antón, R., Treviño, M.Á., Pantoja-Uceda, D., et al. Alternative low-populated conformations prompt phase transitions in polyalanine repeat expansions. *Nat Commun* 15, 1925 (2024). https://doi.org/10.1038/s41467-024-46236-5